GFAP and neurodegenerative disease: Furthermore, GFAP can enter the blood circulation from the brain through the blood-brain barrier, so the changes in protein levels of GFAP in the central nervous system and peripheral blood can reflect the degree of astrocyte damage in neurodegenerative diseases.